Related Experiment Video
Updated: Jul 20, 2026

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
Treatment of myofascial pain syndrome
1Department of Physical Therapy, Hungkuang University, Shalu, Taichung, Taiwan. johnczhong@yahoo.com
Abstract:
Myofascial pain syndrome (MPS) is caused by myofascial trigger points (MTrPs) located within taut bands of skeletal muscle fibers. Treating the underlying etiologic lesion responsible for MTrP activation is the most important strategy in MPS therapy. If the underlying pathology is not given the appropriate treatment, the MTrP cannot be completely and permanently inactivated. Treatment of active MTrPs may be necessary in situations in which active MTrPs persist even after the underlying etiologic lesion has been treated appropriately. When treating the active MTrPs or their underlying pathology, conservative treatment should be given before aggressive therapy. Effective MTrP therapies include manual therapies, physical therapy modalities, dry needling, or MTrP injection. It is also important to eliminate any perpetuating factors and provide adequate education and home programs to patients so that recurrent or chronic pain can be avoided.
Insights
Myofascial pain syndrome (MPS) stems from trigger points in muscles. Effective therapy requires addressing the root cause, followed by trigger point treatment and lifestyle adjustments to prevent recurrence.
Area of Science:
- Pain Management
- Musculoskeletal Disorders
- Physical Medicine
Background:
- Myofascial pain syndrome (MPS) is characterized by myofascial trigger points (MTrPs) within skeletal muscle taut bands.
- The primary goal in MPS therapy is to treat the underlying cause of MTrP activation.
Purpose of the Study:
- To outline the essential therapeutic strategies for managing myofascial pain syndrome.
- To emphasize the importance of addressing the etiologic lesion before or concurrently with active trigger point treatment.
Main Methods:
- Review of current therapeutic approaches for myofascial pain syndrome and trigger points.
- Emphasis on conservative treatments preceding aggressive interventions.
- Inclusion of manual therapies, physical modalities, dry needling, and injections for MTrP treatment.
Main Results:
- Inactivation of MTrPs is often incomplete without addressing the underlying pathology.
- Persistent MTrPs may require direct treatment after the primary cause is managed.
- Eliminating perpetuating factors and patient education are crucial for long-term pain avoidance.
Conclusions:
- Successful myofascial pain syndrome management hinges on identifying and treating the underlying etiologic lesion.
- A stepwise approach, prioritizing conservative methods, is recommended for treating active trigger points.
- Comprehensive patient education and home care programs are vital for preventing chronic or recurrent pain.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Skeletal Muscle Relaxants: Therapeutic Uses
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Layers of Connective Tissue Proper
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
